Back to REGN

REGENERON PHARMACEUTICALS, INC. Proceeds from Debt 2018-2022 | REGN

Beta

What is REGENERON PHARMACEUTICALS, INC.'s current proceeds from debt?

REGENERON PHARMACEUTICALS, INC. (REGN) annual proceeds from debt for 2022 was $0, a NaN% decline from 2021. REGENERON PHARMACEUTICALS, INC. proceeds from debt for the quarter ending September 30, 2021 was $0.

What was REGENERON PHARMACEUTICALS, INC.'s proceeds from debt in 2021?

REGENERON PHARMACEUTICALS, INC. annual proceeds from debt for 2021 was $0, a 100.00% decline from 2020.

What was REGENERON PHARMACEUTICALS, INC.'s proceeds from debt in 2020?

REGENERON PHARMACEUTICALS, INC. annual proceeds from debt for 2020 was $1.98B, a Infinity% increase from 2019.

Proceeds from Debt History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGRN/A
FY2018
$0
→
FY2022
$0
1819202122
4 years selected
Proceeds from Debt History
PeriodValueChangeSource
FY2022$0-10-K
FY2021$0-100.0%10-K
FY2020$1.98B-10-K
FY2019$0-10-K
FY2018$0-10-K
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →